Download PDF
Thromb Haemost 1995; 74(02): 793-794
DOI: 10.1055/s-0038-1649815
Letter to the Editor
Schattauer GmbH Stuttgart

Thrombotic Risk during Pregnancy and Puerperium in Women with APC-Resistance – Effective Subcutaneous Heparin Prophylaxis in a Pregnant Patient

V De Stefano
Divisione di Ematologia, Istituto di Semeiotica Medica, Università Cattolica, Roma, Italy
,
S Mastrangelo
Divisione di Ematologia, Istituto di Semeiotica Medica, Università Cattolica, Roma, Italy
,
K Paciaroni
Divisione di Ematologia, Istituto di Semeiotica Medica, Università Cattolica, Roma, Italy
,
H Ireland
1   Charing Cross and Westminster Medical School, London, UK
,
D A Lane
1   Charing Cross and Westminster Medical School, London, UK
,
P Scirpa
2   Istituto di Clinica Ostetrica e Ginecologica, Università Cattolica, Roma, Italy
,
B Bizzi
Divisione di Ematologia, Istituto di Semeiotica Medica, Università Cattolica, Roma, Italy
,
G Leone
Divisione di Ematologia, Istituto di Semeiotica Medica, Università Cattolica, Roma, Italy
› Author Affiliations
Further Information

Publication History

Received 28 November 1994

Accepted after resubmission 06 March 1995

Publication Date:
06 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004-1008
    CrossrefPubMedGoogle Scholar
  • 2 Koster T, Rosendaal FR, de Ronde H, Briet E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response: Leiden Thrombophilia Study. Lancet 1993; 342: 1503-1506
    CrossrefPubMedGoogle Scholar
  • 3 Svensson PJ, Dahlback B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994; 330: 517-522
    CrossrefPubMedGoogle Scholar
  • 4 Bertina RM, Koeleman BP C, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67
    CrossrefPubMedGoogle Scholar
  • 5 Voorberg J, Roelse J, Koopman R, Biiller H, Berends F, ten Cate JW, Mertens K, van Mourik JA. Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V. Lancet 1994; 343: 1535-1536
    CrossrefPubMedGoogle Scholar
  • 6 Zoller B, Dahlbäck B. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis. Lancet 1994; 343: 1536-1538
    CrossrefPubMedGoogle Scholar
  • 7 Dahlbäck B. Physiological anticoagulation. Resistance to activated protein C and venous thromboembolism J Clin Invest 1994; 94: 923-927
    CrossrefPubMedGoogle Scholar
  • 8 Conard J, Horellou MH, Van Dreden P, Lecompte T, Samama M. Thrombosis and pregnancy in congenital deficiencies in AT III, protein C or protein S: study of 78 women. Thromb Haemost 1990; 63: 319-320
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 De Stefano V, Leone G, Mastrangelo S, Tripodi A, Rodeghiero F, Castaman G, Barbui T, Finazzi G, Bizzi B, Mannucci PM. Thrombosis during pregnancy and surgery in patients with congenital deficiency of antithrombin III. protein C protein S Thromb Haemost 1994; 71: 799-800
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Treffers PE, Huidekoper BL, Weenink GH, Kloosterman GJ. Epidemiological observations of thrombo-embolic disease during pregnancy and in the puerperium in 56,022 women. Int J Gynaecol Obstet 1983; 21: 327-331
    CrossrefPubMedGoogle Scholar
  • 11 Faioni EM, Franchi F, Asti D, Sacchi E, Bemardi F, Mannucci PM. Resistance to activated protein C in nine thrombophilic families: interference in a protein S functional assay. Thromb Haemost 1993; 70: 1067-1071
    Article in Thieme ConnectPubMedGoogle Scholar